Lin Lin

Title: Lin Lin - Innovator in Immunization Technologies

Introduction

Lin Lin is a prominent inventor based in Rancho Palos Verdes, CA (US). He has made significant contributions to the field of immunization against bacterial infections. With a total of 2 patents, Lin Lin is dedicated to developing innovative solutions to combat antibiotic-resistant bacteria.

Latest Patents

Lin Lin's latest patents include groundbreaking compositions and methods for immunization against bacteria expressing a carbapenemase. The first patent provides vaccine and pharmaceutical compositions aimed at treating or preventing bacterial infections. These compositions include a carbapenemase, such as a serine carbapenemase or a metallo-β-lactamase, along with methods for treating and preventing bacterial infections. The second patent focuses on vaccine compositions comprising OmpA and related methods of active immunization against infections. This invention also includes antibodies that specifically bind to OmpA, offering methods of passive immunization against infections, particularly those caused by strains resistant to multiple antibiotics.

Career Highlights

Lin Lin is affiliated with the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. His work is pivotal in addressing the challenges posed by extreme drug-resistant (XDR) and pan-drug resistant (PDR) infections. His research aims to provide effective immunization strategies to combat these critical health threats.

Collaborations

Lin Lin collaborates with esteemed colleagues, including Brad J Spellberg and Ashraf S Ibrahim. Their combined expertise enhances the research efforts in developing innovative immunization methods.

Conclusion

Lin Lin's contributions to immunization technologies are vital in the fight against antibiotic-resistant infections. His innovative patents and collaborative efforts position him as a key figure in the field of medical research.